Human IL6 kit
No-wash kit to quantify released Human IL6
The BDNF HTRF kit is designed for the accurate quantitative measurement of Brain-Derived Neurotrophic Factor produced by cells.
Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family, which also includes nerve growth factor (NGF) and neurotrophins 3 and 4 (NT-3 and NT-4).
BDNF is one of the most widely-studied neurotrophins in healthy or diseased brains. It is secreted by neurons and glial cells, and is strongly regulated by a wide variety of endogenous and exogenous stimuli (e.g. stress, physical activity, brain injury, diet). BDNF plays a crucial role in the control of neuronal and glial development, neuroprotection, and modulation of synaptic interactions, which are critical for cognition and memory.
Decreased levels of BDNF are associated with neurodegenerative diseases such as Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis, and Huntington’s Disease.
BDNF is measured using a sandwich immunoassay involving two specific anti-BDNF antibodies, respectively labeled with an HTRF donor and acceptor dyes. The intensity of the signal is directly proportional to the concentration of BDNF present in the sample.
The assay protocol, using a 384-well small volume white plate or a Cisbio low volume 96-well plate (20 µL final), is described on the right. 16 µL of cell supernatant or standard are dispensed directly into the detection plate for detection by HTRF® reagents. The antibodies labeled with the HTRF donor and acceptor can be pre-mixed and added in a single dispensing step, to further streamline the assay procedure. The assay can be run in 96- to 384-well plates by simply resizing each addition volume proportionally.
|Sample size||16 µL|
|Final assay volume||20 µL|
|Time to results||Overnight at RT|
|Kit components||Lyophilized standard, frozen detection antibodies, buffers & protocol.|
|LOD & LOQ (in Diluent)||5 pg/mL & 31 pg/mL|
|Range||31 – 5,000 pg/mL|
NIBSC (96/534) value (IU/mL) = 0.0012 x HTRF BDNF value (pg/mL)
|Species||Human, mouse, rat, bovine, porcine, canine|
|Specificity||No recognition of NGF, NT-3 and NT-4|
Recombinant BDNF provided in the kit (standard) was serially diluted in diluent #5, following the procedure given in the kit’s package insert. The HTRF signal, expressed as a delta ratio, was plotted as a function of the BDNF concentrations tested.
Each of the 3 samples was measured 24 times, and the % CV was calculated for each sample.
Each of the 3 samples was measured in 5 different experiments, and the % CV was calculated for each sample.
[BDNF] in the cell supernatant
|[Recombinant BDNF] added (pg/mL)|
[Total BDNF] expected
The human microglial cell line HMC3 was seeded in a T75 flask (3 million cells) in complete medium, and cultured until 80% confluence was reached. Cells were then treated or not with 10 ng/mL of human IFN-γ for 24h. Cell supernatants were collected, and secreted levels of BDNF were measured following the procedure given in the HTRF kit’s package insert.
In accordance with the literature, IFN-γ treated microglial cells displayed a decrease in BDNF release.
Human iPSC-derived astrocytes (Astro.4U®, Ncardia) were plated in a 96-well poly-L-ornithine/laminin-coated plate and cultured for 7 days. Cells were then treated or not with a cocktail of human pro-inflammatory cytokines (10 ng/mL TNF-α + 100 ng/mL IL-1β + 100 ng/mL IFN-γ) for 24h. Cell supernatants were collected, and secreted levels of BDNF were measured following the procedure given in the HTRF kit’s package insert.
As expected, the concentration of BDNF released by astrocytes increased significantly when cells were exposed to the cocktail of pro-inflammatory cytokines.
Astrocytes are very sensitive to their environment and respond quickly in response to CNS damage. Activated signaling pathways lead to pro- or anti-inflammatory phenotypes.
In response to some cytokines and growth factors, astrocytes activate the Jak/STAT3 pathway, which is thought to be responsible for the upregulation and secretion of many neurotrophic and neuroprotective factors promoting neuron survival and synapse repair, including BDNF.
Get the brochure about technology comparison. - Brochures
The essential guide for extending your knowledge on the molecular mechanisms of neurodegenerative diseases - Guides
Discover this infographic design on neurodegenerative diseases - Infographics
See published experiments and data demonstrating how immunoassays rise to the challenge of astrocyte studies in neuroinflammation research - Application Notes
New insight into neuroinflammation research - Videos
Choosing the right microplate reader ensures you’ll get an optimal readout. Discover our high performance reader, or verify if your lab equipment is going to be compatible with this detection technology.Let's find your reader
Phospho-AKT1/2/3 (Ser473) cellular kit
Simple, all-in-one kit for robust detection of Phospho-ATK & Total ATK
Phospho-ERK (Thr202/Tyr204) cellular kit
Simple, all-in-one kit for robust detection of Phoshpo- & Total ERK